Improved survival of patients with unresectable non-small-cell bronchogenic carcinoma by an innovated high-dose en-bloc radiotherapeutic approach. [Photons]
From 1972 to 1977, 162 patients were treated with definitive radiotherapy for the underlying unresectable non-small-cell bronchogenic carcinoma by a radiotherapeutic technique that had sequentially evolved from a low-dose (40 to 45 gray) small-volume approach (AP-PA POP) to a high-dose (60 to 64 gray) large-volume en-bloc approach (AP-PA POP plus AP-RPO-LPO) which included the primary tumor and the entire regional lymphatics including both supraclavicular areas. Median survival and short-term survival up to 1.5 years were independent of radiation doses (40 to 64 gray) and target volumes studies. However, long-term survival greater than or equal to 2 years was radiation-dose and target-volume dependent. Actuarial five-year survival rate 7.5% was obtained with radiation dose greater than or equal to 50 gray. However, there was no survivor among patients who were treated with radiation dose < 50 gray. Local tumor control is radiation-dose dependent. The patterns of failure appeared to be tumor-histology dependent; for squamous cell carcinoma, the primary and regional lymphatic areas are the most common sites of failure, and for adenocarcinoma, it is the brain or bone. The high-dose en-bloc radiotherapy has been very well tolerated; 5% (4/80) incidence of symptomatic pneumonitis has been observed.
- Research Organization:
- Harvard Medical School, Boston, MA
- OSTI ID:
- 6200286
- Journal Information:
- Cancer; (United States), Journal Name: Cancer; (United States) Vol. 48:1; ISSN CANCA
- Country of Publication:
- United States
- Language:
- English
Similar Records
Basis for new strategies in postoperative radiotherapy of bronchogenic carcinoma
Radiotherapy of bronchogenic carcinoma: analysis of a treatment schedule designed for use with hyperbaric oxygen. [/sup 60/Co]
Related Subjects
560151* -- Radiation Effects on Animals-- Man
62 RADIOLOGY AND NUCLEAR MEDICINE
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
BODY
CARCINOMAS
DISEASES
ELEMENTARY PARTICLES
ENERGY RANGE
FIBROSIS
ISODOSE CURVES
LUNGS
LYMPH NODES
LYMPHATIC SYSTEM
MASSLESS PARTICLES
MEDICINE
MEV RANGE
MEV RANGE 01-10
MYELITIS
NAUSEA
NEOPLASMS
NERVOUS SYSTEM DISEASES
NUCLEAR MEDICINE
ORGANS
PATHOLOGICAL CHANGES
PATIENTS
PHOTONS
PNEUMONITIS
RADIOINDUCTION
RADIOLOGY
RADIOTHERAPY
RESPIRATORY SYSTEM
SIDE EFFECTS
SYMPTOMS
THERAPY